ECG Telemetry Devices Market Size, Share & Industry Analysis, By Product Type (Telemetry Transmitters, Patient-Worn Telemetry Monitors, Mobile Cardiac Telemetry (MCT) Devices, and Others), By Monitoring Environment (In-Hospital/Facility-Based ECG Telemetry and Outpatient/Mobile Cardiac Telemetry), By Application (Arrhythmia Monitoring, Ischemia Monitoring, QT/QTc Monitoring, and Others), By End User (Hospitals & ASCs, Specialty Clinics, Diagnostic Centers, and Others), and Regional Forecast, 2026-2034

The global ECG telemetry devices market size was valued at USD 2.17 billion in 2025. The market is projected to grow from USD 2.35 billion in 2026 to USD 4.55 billion by 2034, exhibiting a CAGR of 8.6% during the forecast period.

An ECG telemetry device is a small, portable or body-worn medical device that continuously records the electrical activity of a patient's heart and wirelessly transmits the data to a central monitoring station. The growing prevalence of chronic conditions, increasing patient pool, advances in ECG monitoring technologies, rising demand for telemetry solutions, and the expansion of healthcare infrastructure are driving market growth.

The growing focus on AI integration and patient-centric healthcare solutions among major companies, including Koninklijke Philips N.V. and GE HealthCare, is further contributing to the demand for these devices.

ECG Telemetry Devices Market Trends

Incorporation of Artificial Intelligence and Advanced Algorithms to Boost Industry Expansion

The incorporation of artificial intelligence and deep learning algorithms is emerging as a key trend in the market. Continuous ECG telemetry generates large volumes of cardiac waveform data, driving the adoption of AI-enabled algorithms, which continuously analyze ECG signals, prioritize clinically significant events, identify abnormal rhythms, quantify atrial fibrillation burden, and minimize the number of inconclusive recordings requiring manual interpretation. This is particularly valuable in mobile cardiac telemetry and wearable ECG monitoring, where patients may generate several days or weeks of continuous ECG data.

• For instance, according to 2026 data published by the National Center for Biotechnology Information (NCBI), it was reported that an AI algorithm achieved 96.2% sensitivity for atrial fibrillation detection.

Market Dynamics

Market Drivers

Download Free sample to learn more about this report.

Increasing Prevalence of Chronic Diseases to Drive Market Growth

The growing prevalence of chronic conditions, including ischemic heart disease and diabetes, is resulting in an increasing number of patient admissions in healthcare facilities, consequently boosting demand for these products.

• For instance, according to 2025 data published by the National Center for Biotechnology Information (NCBI), approximately 126 million individuals were affected by ischemic heart disease globally.

This, along with a growing geriatric population, increasing healthcare expenditure, and the expansion of telemetry services, is fueling the adoption rate of ECG telemetry devices in the market. Increasing emphasis by key companies on investing in R&D to develop and launch novel devices is fueling global ECG telemetry devices market growth.

Market Restraints

High Cost Associated with Advanced Devices to Limit Market Growth

The high cost of advanced ECG telemetry devices is a major restraint in the global market. Hospital telemetry deployments require multiple patient-worn transmitters, central monitoring stations, receivers and access points, dedicated wireless infrastructure, gateways, software platforms, servers, alarm-management tools, and integration with electronic medical records and hospital information systems. These requirements increase the overall cost associated with procurement, software licensing, and data integration. The increasing cost burden, coupled with inadequate reimbursement infrastructure, makes adoption challenging for outpatient departments, small hospitals, specialty clinics, and healthcare providers in emerging countries.

Market Opportunities

Increasing Number of Ambulatory Surgical Centers (ASCs) to Fuel Industry Growth

There is an ongoing expansion of healthcare facilities in emerging countries, including Brazil, India, Mexico, and others. Increasing patient admissions, growing healthcare expenditure, and a rising number of ambulatory surgical centers (ASCs) are consequently driving the adoption of ECG telemetry devices in healthcare facilities. The preference for ambulatory surgical centers has increased due to their benefits, including shorter patient stays, lower procedural costs, faster turnover times, and limited risk of hospital-acquired infections.

• According to 2025 data published by Definitive Healthcare, it was reported that there were approximately 10,000 active ambulatory surgical centers (ASCs) in the U.S.

Market Challenges

Limited Healthcare Access in Emerging Countries to Limit Market Growth

There is a growing demand for telemetry systems among the patient population. However, the limited availability of technologically advanced devices, restricted healthcare expenditure, along with inadequate insurance coverage, especially in emerging countries, are hampering access to healthcare facilities.

Furthermore, a limited number of healthcare facilities, limited healthcare professionals, integration challenges with healthcare IT systems, and stringent regulatory requirements are limiting the adoption rate among the patient population, especially in emerging countries, including India and Mexico.

• For instance, according to 2023 data published by The World Bank Group (WBG), about 4.5 billion people lack full access to essential health services globally.

SEGMENTATION ANALYSIS

By Product Type

Rise in Patient Admissions Boosted Telemetry Transmitters Segment Growth

Based on product type, the market is classified into telemetry transmitters, patient-worn telemetry monitors, mobile cardiac telemetry (MCT) devices, and others.

The telemetry transmitters segment held the largest share in 2025. The growth is driven by the increasing number of patient admissions globally, resulting in an increasing focus by key companies on launching patient monitoring systems, including telemetry transmitters.

The mobile cardiac telemetry (MCT) devices segment is expected to grow at a CAGR of 11.2% over the forecast period.

To know how our report can help streamline your business, Speak to Analyst

By Monitoring Environment

In-Hospital/Facility-Based ECG Telemetry Segment Led Market Due to Availability of Trained Healthcare Professionals

Based on monitoring environment, the market is segmented into in-hospital/facility-based ECG telemetry and outpatient/mobile cardiac telemetry.

The in-hospital/facility-based ECG telemetry segment dominated the global market in 2025. An increasing number of patient admissions, expansion of hospital infrastructure, and growing adoption of advanced wireless patient-monitoring systems are supporting the use of ECG telemetry devices in hospital settings. The availability of trained healthcare professionals and centralized monitoring infrastructure in hospitals further supports the adoption of these systems, contributing to the segment’s dominance.

For instance, according to 2026 data published by Feather, it was reported that there are 1,874 hospitals in Germany.

The outpatient/mobile cardiac telemetry segment is expected to grow at a CAGR of 10.5% during the forecast period.

By Application

Increasing Patient Admissions for Cardiovascular Conditions Boosted Arrhythmia Monitoring Segment Dominance

Based on application, the market is segmented into arrhythmia monitoring, ischemia monitoring, QT/QTc monitoring, and others.

The arrhythmia monitoring segment dominated the global market in 2025. The segment’s dominance is primarily attributed to the increasing prevalence of cardiac arrhythmias and the growing need for continuous and real-time heart rhythm monitoring. Additionally, increasing patient admissions for cardiovascular conditions and the growing use of remote and ambulatory cardiac monitoring solutions are contributing to the adoption of arrhythmia monitoring devices.

• For instance, according to the 2023 data published by the First Coast Heart and Vascular Center, about 2.7 million people are diagnosed with arrhythmia each year in the U.S.

The ischemia monitoring segment is expected to grow at a CAGR of 7.3% during the forecast period.

By End-user

Hospitals & ASCs Segment Led Market Due to Easy Accessibility of Advanced ECG Telemetry Devices

Based on end user, the market is divided into hospitals & ASCs, specialty clinics, diagnostic centers, and others.

The hospitals & ASCs segment dominated the market in 2025. The growing adoption of advanced ECG telemetry devices in hospitals, the growing patient pool in hospitals and ambulatory surgical centers, and the increasing number of hospitals are favoring segment growth. Furthermore, the segment is set to hold a 62.8% share in 2026.

• For instance, according to 2026 data published by the American Hospital Association (AHA), there are about 6,100 hospitals in the U.S.

The specialty clinics segment is projected to grow at a CAGR of 10.3% during the forecast period.

ECG Telemetry Devices Market Regional Outlook

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America held the dominant ECG telemetry devices market share in 2024, valued at USD 0.87 billion, and maintained its leading share in 2025 with USD 0.95 billion. The increasing patient population requiring cardiac monitoring, growing healthcare expenditure, increasing demand for remote patient monitoring devices, and technological advancements in these cardiac event monitors are driving market growth.

• For instance, according to 2026 data published by the Centers for Medicare & Medicaid Services (CMS), healthcare spending is about USD 5.3 trillion in the U.S.

U.S. ECG Telemetry Devices Market

Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market is expected to reach around USD 0.93 billion in 2026, accounting for roughly 39.6% of global sales.

Europe

Europe is projected to record a CAGR of 7.2% during the forecast period, which is the second-highest among all regions. The market is expected to reach a valuation of USD 0.60 billion in 2026. The growing prevalence of chronic conditions and growing adoption rate of cardiovascular monitoring devices are likely to support market growth.

U.K. ECG Telemetry Devices Market

The U.K. market in 2026 is estimated to reach around USD 0.11 billion, representing roughly 4.8% of global revenues.

Germany ECG Telemetry Devices Market

The German market is projected to reach approximately USD 0.14 billion in 2026, equivalent to around 5.9% of global sales.

Asia Pacific

Asia Pacific is estimated to reach USD 0.51 billion in 2026 and secure the position of the third-largest region in the market. Growth patient admissions, expanding hospital capacity, and growing healthcare access are likely to support the growth of the market.

Japan ECG Telemetry Devices Market

The Japanese market is estimated to reach around USD 0.13 billion in 2026, accounting for roughly 5.4% of global revenues.

China ECG Telemetry Devices Market

The market in China is projected to be one of the largest globally, with 2026 revenues standing at around USD 0.17 billion, representing roughly 7.0% of global sales.

India ECG Telemetry Devices Market

The Indian market size in 2026 is estimated at around USD 0.06 billion, accounting for roughly 2.6% of global revenues.

Latin America and Middle East & Africa

The Latin America and Middle East & Africa regions are expected to witness moderate growth in this market during the forecast period. The Latin American market is set to reach a valuation of USD 0.12 billion in 2026 due to increasing demand for continuous ECG monitoring devices and growing acquisitions among key companies. The Middle East & Africa region is also expected to witness considerable growth, owing to growing R&D activities among key companies to launch wearable ECG devices in the market. In the Middle East & Africa, the GCC market is set to reach USD 0.04 billion in 2026.

South Africa ECG Telemetry Devices Market

The South African market is projected to reach around USD 0.02 billion in 2026, representing roughly 1.0% of global revenues.

Competitive Landscape

Key Industry Players

Increasing Focus on Product Launches by Top Companies to Support Their Market Positions

A broad product portfolio, along with a strong focus on inorganic growth strategies globally, is one of the major factors contributing to the dominance of leading companies in the ECG telemetry devices market. Koninklijke Philips N.V., and GE HealthCare were among the major companies in the market in 2025. Additionally, the growing focus of key companies on R&D activities to launch, develop, and introduce innovative devices is likely to strengthen companies’ market presence.

• For instance, in September 2025, Koninklijke Philips N.V., launched its next-generation smart telemetry platform and Telemetry Monitor 5500, designed for enterprise-wide continuous cardiac monitoring beyond the bedside, alarm management, and patient mobility.

Other key players, including Boston Scientific Corporation, are also expanding their presence in the market, primarily due to their growing focus on acquisitions of other companies to strengthen their brand presence.

List of Key ECG Telemetry Device Companies Profiled

• Koninklijke Philips N.V. (Netherlands)
• GE HealthCare (U.S.)
• NIHON KOHDEN CORPORATION (Japan)
• FUKUDA DENSHI (Tokyo)
• Spacelabs Healthcare (U.S.)
• Masimo (U.S.)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
• iRhythm Technologies, Inc. (U.S.)
• Boston Scientific Corporation (U.S.)
• VitalConnect (U.S.)

KEY INDUSTRY DEVELOPMENTS

• December 2025: GE HealthCare and University of Rochester Medical Center (URMC) announced a Care Alliance to build advanced capabilities across URMC’s footprint in the U.S., including standardization of patient monitoring across the entire UR Medicine health system, and others.
• September 2025: VivaLNK, Inc., a provider of digital healthcare solutions, launched its new wearable ECG sensor adhesive that improves the detection of P-waves during ambulatory cardiac monitoring.
• September 2025: ScottCare, a company in cardiopulmonary rehabilitation, launched Aermos, a new telemetry and program management system for cardiac and pulmonary rehabilitation.
• March 2025: MEDICALGORITHMICS signed a distribution agreement with Health Test Australia for PocketECG, which can switch between Holter, event-monitoring, and multi-week MCT modes.
• February 2021: Koninklijke Philips N.V., a company in health technology, acquired BioTelemetry, Inc., a U.S.-based provider of remote cardiac diagnostics and monitoring with an aim to strengthen its presence.

REPORT COVERAGE

The report provides a detailed global ECG telemetry devices market analysis and focuses on key aspects such as leading companies and market segmentation, including product type, monitoring environment, application, and end user. Besides this, the global report offers insights into the market growth trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth and advancement of the market over recent years.

Request for Customization   to gain extensive market insights.

Report Scope and Segmentation

Research Methodology

1. Bottom-Up Approaches

Approach 1: Revenues and Market Share of Major ECG Telemetry Players

• Collect company and segment revenue from annual reports, SEC filings, investor presentations, earnings releases, product portfolios, and regulatory disclosures.
• Map in-scope telemetry transmitters, patient-worn telemetry monitors, and MCT devices across Philips, GE HealthCare, Mindray, Nihon Kohden, Boston Scientific, iRhythm, and other key suppliers.
• Attribute only ECG-telemetry-device revenue from broad patient-monitoring or ambulatory-service revenue pools; exclude monitoring-center services, physician interpretation and distributor margins.
• Estimate company revenue using product breadth, installed base, geographic exposure, device shipments, replacement cycles, and manufacturer ASPs.
• Triangulate company totals against country demand and procurement evidence to derive global market value.

Approach 2: Device-Level Installed Base, Replacement and ASP Analysis

• Establish installed base of hospital telemetry transmitters and patient-worn monitors by country and care setting.
• Estimate annual replacements using device useful life, loss/damage, technology upgrades, and telemetry-bed expansion.
• Estimate MCT device volumes from monitoring episodes, device reuse rates, and active device pool requirements.
• Apply manufacturer-level ASPs by product type and geography, then aggregate device value from country to regional/global level.
• Reconcile hardware value with public procurement and commercial price references to avoid over/under-estimation.

Approach 3: Clinical Utilization and Eligible-Monitoring Model

• Assess inpatient telemetry utilization, monitored bed capacity, and patient throughput for arrhythmia, ischemia, and QT/QTc surveillance.
• Estimate outpatient MCT prescriptions using arrhythmia burden, symptom evaluation, post-treatment surveillance, and cardiology/EP capacity.
• Map monitoring volumes to devices required after accounting for wear duration, reuse/turnaround and service logistics.
• Apply device-only economic value rather than reimbursed technical/professional service value.
• Aggregate country-level utilization estimates to regional and global market values.

2. Top Down Approaches

Approach 1: Analysis of Parent Patient Monitoring and Ambulatory ECG Monitoring Markets

• Analysis of the global patient monitoring and ambulatory cardiac monitoring equipment universe as the primary addressable parent market for ECG telemetry devices, using manufacturer revenues, patient-monitor shipments, installed-base data, hospital infrastructure, and national healthcare statistics.
• Identification of the proportion of patient-monitoring expenditure attributable specifically to ECG telemetry, separating telemetry transmitters, patient-worn telemetry monitors, and Mobile Cardiac Telemetry (MCT) devices from bedside multiparameter monitors, conventional Holter monitors, resting ECG systems, event-only recorders, implantable monitors, and monitoring services.
• Estimation of the share represented by In-Hospital/Facility-Based ECG Telemetry and Outpatient/Mobile Cardiac Telemetry, using manufacturer portfolios, hospital telemetry installations, ambulatory ECG utilization, and cardiac-monitoring procurement activity.
• Application of country-specific ECG telemetry penetration rates using the number of hospitals, staffed hospital beds, telemetry-capable beds, cardiac/step-down units, cardiology departments, diagnostic centers, electrophysiology practices, and ambulatory cardiac-monitoring volumes.
• Adjustment for differences in manufacturer selling prices, device configuration, wireless architecture, number of monitored parameters, reusable versus disposable components, device sophistication, and developed- versus emerging-market pricing.
• Incorporation of replacement demand by applying country-specific installed-base age profiles and typical replacement cycles for telemetry transmitters, patient-worn monitors, central telemetry receivers/gateways, and related in-scope hardware.
• Adjustment for clinical utilization across Arrhythmia Monitoring, Ischemia Monitoring, QT/QTc Monitoring, and Others, using cardiovascular disease burden, arrhythmia prevalence, inpatient cardiac-monitoring intensity, ambulatory MCT prescriptions, and post-treatment surveillance requirements.
• Allocation of the resulting market estimate across Hospitals & ASCs, Specialty Clinics, Diagnostic Centers, and Others, based on equipment ownership, purchasing patterns, MCT prescribing/referral activity, installed-base distribution, and facility-level utilization.
• Aggregation of country-level ECG telemetry device estimates into regional and global market values and comparison with manufacturer-revenue, installed-base, device-volume, procurement, and ASP-based bottom-up estimates.
• Final adjustment to exclude remote cardiac monitoring service revenues, physician interpretation fees, hospital service revenues, conventional Holter-only devices, event-only recorders, implantable cardiac monitors, consumer ECG wearables, generic bedside monitors, distributor markups, and other out-of-scope revenues before deriving the Global ECG Telemetry Devices Market size.

3. List of Key Sources

• Annual reports, SEC filings, investor presentations, earnings releases, and company disclosures
• Company websites, product portfolios, technical datasheets, and regulatory clearance announcements
• U.S. FDA 510(k), De Novo, PMA, device classification, recall, and registration databases
• European Commission, EU MDR, CE Marking, EUDAMED, and national regulatory authorities
• PMDA/MHLW, NMPA, CDSCO, and TGA/ARTG databases
• American Heart Association (AHA), American College of Cardiology (ACC), Heart Rhythm Society (HRS), ISHNE, ESC, and EHRA
• CMS, Medicare Coverage Database, CPT/HCPCS, DRG, and national reimbursement databases
• WHO, OECD, Eurostat, World Bank, and national health/statistical agencies
• Hospital associations, hospital bed/capacity databases, procurement portals, tenders, and equipment purchasing records
• Peer-reviewed journals, PubMed/NCBI, clinical studies, and cardiovascular/arrhythmia registries
• ISO and IEC standards including ISO 13485, ISO 14971, IEC 60601, and IEC 62304
• Product approvals, launches, M&A, partnerships, distribution agreements, hospital installations, and reimbursement updates

4. Primary Interviews

Supply Side Interviews: 60%

• Key Respondents:
• ECG telemetry and patient-monitoring manufacturers
• MCT device/product managers and cardiac diagnostic providers
• Commercial, product and sales executives
• Regulatory affairs, quality and cybersecurity professionals
• Manufacturing, supply-chain and service executives
• Medical-device distributors and tender/procurement specialists
• Demand Side Interviews: 40%
• Key respondents:
• Cardiologists and electrophysiologists
• Hospital telemetry/nursing leaders and monitor technicians
• Biomedical engineering and hospital IT/clinical engineering teams
• Hospital/ASC procurement and value-analysis managers
• Diagnostic center/IDTF and remote cardiac monitoring managers
• Payers, reimbursement specialists and health technology assessment experts